about
IGF-I in the clinics: Use in retinopathy of prematurityInsulin-like growth factor 1 has multisystem effects on foetal and preterm infant developmentThe mouse retina as an angiogenesis model.Quantification and localization of the IGF/insulin system expression in retinal blood vessels and neurons during oxygen-induced retinopathy in mice.Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safetyImportance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity.Low birth weight is a risk factor for severe retinopathy of prematurity depending on gestational age.Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy.Neonatal IGF-1/IGFBP-1 axis and retinopathy of prematurity are associated with increased blood pressure in preterm childrenWINROP identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infantsDietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin.Weight at first detection of retinopathy of prematurity predicts disease severity.Longitudinal postnatal weight measurements for the prediction of retinopathy of prematurity.Effect of Preterm Birth on Postnatal Apolipoprotein and Adipocytokine ProfilesSerum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.A pharmacokinetic and dosing study of intravenous insulin-like growth factor-I and IGF-binding protein-3 complex to preterm infantsIncreased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesisIGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.White matter damage after chronic subclinical inflammation in newborn mice.Cohort study of growth patterns by gestational age in preterm infants developing morbidity.New insights into the development of retinopathy of prematurity--importance of early weight gain.Review: adiponectin in retinopathy.Maternal and neonatal factors associated with poor early weight gain and later retinopathy of prematurity.Prediction of retinopathy of prematurity using the screening algorithm WINROP in a Mexican population of preterm infants.Fresh-frozen plasma as a source of exogenous insulin-like growth factor-I in the extremely preterm infant.Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulinlike growth factor I.Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening.Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.Prediction of severe retinopathy of prematurity using the WINROP algorithm in a birth cohort in South East Scotland.Circulatory insulin-like growth factor-I and brain volumes in relation to neurodevelopmental outcome in very preterm infants.Construction of a soluble human GH-receptor/EGF-receptor hybrid and its activation by GH.The use of the WINROP screening algorithm for the prediction of retinopathy of prematurity in a Chinese population.Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit.Role of Insulinlike Growth Factor 1 in Fetal Development and in the Early Postnatal Life of Premature Infants.Safety aspects of longitudinal administration of IGF-I/IGFBP-3 complex in neonatal mice.Oxygen Monitoring Reduces the Risk for Retinopathy of Prematurity in a Mexican Population.Efficacy of the screening algorithm WINROP in a Korean population of preterm infants.WINROP can modify ROP screening praxis: a validation of WINROP in populations in Sörmland and Västmanland.Predicting proliferative retinopathy in a Brazilian population of preterm infants with the screening algorithm WINROP.Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence.
P50
Q28070089-7AF787A1-B0A0-4E19-BCC1-D928A821980DQ28073109-3BDA3E65-0277-4B44-836D-62997D25B93AQ30495106-D4E70877-A061-4454-A830-1E6361733747Q30853111-E8DCA963-AE79-4C70-82B3-35D728773BE0Q33640027-E20AB2E2-48BD-4B77-A065-FE08B07D478CQ33760906-9E770E75-CA61-448A-B58E-5FA38581270FQ34343703-9FC5A6FB-4503-43D1-B265-E8B1D81B7947Q34358139-9F267D5B-C81F-4743-8311-7052E577B9BDQ34617800-27C0EE9D-A03B-4FF6-AF78-AA69B94CD2D4Q34998606-A4461C6C-6BD9-4132-98A6-E7F1EDC5B0B6Q35239541-1597D3E2-43D6-41E1-A771-D4F0A1BFCD6AQ35316451-59A56CE7-5E33-497B-8526-86D6E88F23E4Q35370567-1741A4A8-11EE-4DC6-B6ED-6709D66D2960Q35762978-1E325007-C65C-4F63-AF9D-553116FA1E9DQ35776253-638FEF6B-1A62-4569-9FE2-E7A04D838A0AQ35800245-02A5CD6B-27D7-48DF-ADB8-7CC6C2B8DAFDQ35817458-1C226D6B-689E-4097-A6EF-0248D10FA88EQ35973404-B898840B-FC21-4490-B124-3E92211C5EE9Q36907520-1418957D-8DF3-4EE0-BABE-F2CC7403AEEAQ37454261-9BFF5886-9614-4115-A302-65CB757530D8Q37624795-F98E1A53-FE2F-4417-873E-96DEC295B740Q38828260-F21773E9-16D2-4498-835B-C2634837B0C3Q39732653-0965925F-D586-462A-9E5D-CAE809244EC2Q44856357-1BA94404-6E5C-4D75-804F-6A0220A9AD3FQ46252948-8D7DFD0A-26CF-4E63-8A69-A275FAF7319DQ47184529-EEE2E319-E4B4-4633-AA89-F07BD26D4B82Q47191959-56105534-16F6-40BD-B8EC-B28C7529E089Q47310528-CC49572D-D254-4B06-8EF0-8AB00987D59AQ47679810-09D66F92-CB3E-4C76-AC5A-D3512F5D7C00Q47785163-1C48EA91-17F5-4210-B49E-0D2BEC9E616AQ47909667-12C0B3FB-46E1-4BD0-8E7E-029A811E0944Q47932135-FB528A47-333A-45A4-B892-F370A7041251Q48513744-61AA1680-40A6-4F2D-9F72-09F86262F190Q48526161-602085D5-6F6E-470C-A2BF-B43535C21B9EQ49138949-04E05534-0BA4-4526-9BDD-06561F955D04Q50664363-D308728E-A1E0-41C2-926A-334DB5599972Q50881002-079E7E05-3933-488B-B139-80FD35B9A664Q51108401-8004F3BA-CF4B-49D8-AB02-61FD3EB895E2Q51639461-0E7040BB-B8A8-4B09-93A6-04BCE1C4F2B1Q51982410-5935AE57-123C-4F62-8A3F-456D464C99AC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chatarina Löfqvist
@ast
Chatarina Löfqvist
@en
Chatarina Löfqvist
@es
Chatarina Löfqvist
@nl
Chatarina Löfqvist
@sl
type
label
Chatarina Löfqvist
@ast
Chatarina Löfqvist
@en
Chatarina Löfqvist
@es
Chatarina Löfqvist
@nl
Chatarina Löfqvist
@sl
altLabel
Chatarina Jansson
@en
prefLabel
Chatarina Löfqvist
@ast
Chatarina Löfqvist
@en
Chatarina Löfqvist
@es
Chatarina Löfqvist
@nl
Chatarina Löfqvist
@sl
P106
P21
P31
P496
0000-0003-4371-5164